Badger Meter, Inc. — Scientific & Technical Instruments. Scored on the same transparent 7-signal model behind the daily rankings.
★
BMI
Badger Meter, Inc. · Scientific & Technical Instruments
FCF$169mC
Rev+10.9%B
D/E0.02A
P/E33.0xB
PEG3.74D
70.4Score
$145.31$4.2B
1Y Target$153.22Analyst consensus · 9 analysts
5Y Target$224.33Compound horizon
10Y Target$332.78Long-dated conviction
FCF$169mTTMC
FCF $169m — modest; watch for margin expansion
Rev+10.9%TTM YoYB
Revenue +10.9% — at or above S&P median
D/E0.02A
D/E 0.02 — least levered decile in Technology (≈10th pctile)
P/E33.0xB
P/E 33.0 — near the Technology median (≈60th pctile)
PEG3.74D
PEG 3.74 — very expensive; pricing in best-case scenarios
Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.
Quality-growth score · 70.4
Quality0.88
Growth0.85
Value0.47
Why this score
Raising its dividend
Durable high returns
Entry · Margin of safety
52-week rangeNear 52-week low
42% off the 12-month high
vs DCF fair value1% belowest. fair value ~$147
What the price assumes: free cash flow compounding at ~8% a year for the next decade — vs the ~12% a year our model projects from current growth and analyst estimates.
Quality signals · context only
Gross profitability38% · B+gross profit ÷ total assets (Novy-Marx)
ROIC19.4% · A-return on invested capital — not score-weighted
Why now
Scientific & Technical Instruments · market cap $4.2b. Down 42% from 52-week high of $249.56 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median. 9 sell-side analysts rate this a Buy with a mean 1-yr target of $153.22 (implying +5% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 129% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 42% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 33x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Horizon
1-3 yr $153.22 (9-analyst consensus) — fundamentals + valuation re-rating. 5 yr $224.33 at ~9% CAGR — compounding case rests on the competitive position widening. 10 yr $332.78 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Score history · BMI
Trend
-0.2 over 15 daily scores
From 70.6 (Jun 22) → 70.4 (now)
One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.
Position sizing · BMI
$
%
%
Shares to buy
13
Position size
$1,889
3.8% of portfolio
Stop price
$108.98
25% below $145.31
$ at risk if stopped
$472.26
budget $500.00 · 1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Badger Meter, Inc. (BMI): score, valuation & FAQ
Badger Meter, Inc. (BMI) is a Scientific & Technical Instruments company that scores 70.4 out of 100 on the Bull Rankings quality-growth model — a solid, above-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are D/E (A), while PEG (D) rate weaker. On valuation, BMI sits close to our DCF fair-value estimate (within a few percent) — the current price implies roughly 8% annual free-cash-flow growth over the next decade.
Is BMI a good stock to buy?
Bull Rankings scores BMI 70.4 out of 100 on its quality-growth model, which is a solid, above-average reading. That is driven by D/E (A). A score is a quantitative screen of Badger Meter, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does BMI score 70.4 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). BMI earns its highest marks on D/E (A), and is held back by PEG (D). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is BMI overvalued or undervalued?
Based on $145.31, BMI sits close to our DCF fair-value estimate (within a few percent) — the current price implies roughly 8% annual free-cash-flow growth over the next decade. It trades at a 33.0x× P/E (graded B). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in BMI?
Down 42% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 33x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial adviser.